Meloxicam Al (Meloxicam)

Meloxicam works by selectively blocking the cyclooxygenase‑2 (COX‑2) enzyme, which is responsible for converting arachidonic acid into prostaglandins that drive inflammation, pain and fever. By reducing prostaglandin production in inflamed tissues, meloxicam diminishes swelling, redness and the perception of pain.

The appropriate dose of Meloxicam Al is determined by the prescribing clinician based on the patient’s specific condition, severity of symptoms, age, renal and hepatic function, and any concomitant medications. Dosage regimens are individualized and should follow the prescriber’s instructions without deviation.

Safety data for meloxicam during pregnancy and lactation are limited. It is generally advised to avoid use in the first trimester and to consider alternative therapies unless the potential benefit outweighs the risk. Meloxicam is excreted in breast milk, so breastfeeding mothers should consult their healthcare provider before use.

To order Meloxicam Al, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets, and will request verification of trade or institutional credentials. The sales team will then respond with pricing, availability, shipping details and any necessary import documentation.

Meloxicam has a longer half‑life than ibuprofen and naproxen, allowing once‑daily dosing for many patients. It is more selective for COX‑2, which may reduce the incidence of gastrointestinal irritation compared with non‑selective NSAIDs, but it still carries cardiovascular and renal risks that require monitoring.

Meloxicam Al should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and excessive heat to maintain its stability and potency throughout its shelf life.

Meloxicam Al is administered orally, usually as a tablet or capsule, and should be taken with a full glass of water. It can be taken with or without food, but taking it with food may help reduce mild gastrointestinal discomfort.

Serious risks include gastrointestinal bleeding or ulceration, cardiovascular events such as heart attack or stroke, severe skin reactions (e.g., Stevens‑Johnson syndrome), and liver or kidney impairment. Patients should seek immediate medical attention if they notice black stools, chest pain, sudden swelling, rash, or jaundice.

Meloxicam Al should be avoided in individuals with known hypersensitivity to meloxicam or other NSAIDs, those with active gastrointestinal ulceration or bleeding, severe heart failure, uncontrolled hypertension, significant renal or hepatic impairment, and in patients who are in the late stages of pregnancy unless absolutely necessary.